Adalimumab and methotrexate is more effective than adalimumab alone in patients with established rheumatoid arthritis: results from a 6-month longitudinal, observational, multicentre study. [electronic resource]
Producer: 20061128Description: 1379-83 p. digitalISSN:- 0003-4967
- Adalimumab
- Adult
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Drug Therapy, Combination
- Female
- Humans
- Longitudinal Studies
- Male
- Methotrexate -- adverse effects
- Middle Aged
- Severity of Illness Index
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.